Skip to main content

Table 1 Clinico-pathological features of lung cancer cases (N =96)

From: Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients

Group Characteristics Number (%)
Sex   
  Male 73(76.04%)
  Female 23(23.96%)
Age   
  <60 54(56.25%)
  ≥60 42(43.75%)
Pack years of smoking   
  >40 47(48.96%)
  20.1–40 4(4.17%)
  0.1–20 8(8.33%)
  0 37(38.54%)
Histology   
  LAC 41(42.71%)
  LSCC 39(40.63%)
  SCLC 11(11.46%)
  LCLC 3(3.13%)
  Undifferentiated 2(2.83%)
Pathologic grade   
  Poorly differentiated 26(27.08%)
  Moderately differentiated 33(34.38%)
  Well-differentiated 21(21.88%)
  Others 16(16.67%)
Clinical staging   
  IB 3(3.1%)
  IIA-IIB 53(55.3%)
  IIIA-IIIB 25(26.04%)
  IV 4(4.1%)
  Unavailable 11(11.46%)
Pleural invasion   
  Absent 82(85.42%)
  Present 14(14.58%)
Lymphatic invasion   
  Positive 55(57.29%)
  Negative 41(42.71%)
  1. LAC, lung adenocarcinoma; LSCC, lung squamous cell carcinoma; SCLC, small cell lung cancer; LCLC, large cell lung cancer.